Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen Spraggon

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
The Biochemical Journal|July 31, 2013
Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureusChristina Schluepen, Enrico Malito, Ambra Marongiu, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2006
Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethersDavid C Tully, Hong Liu, Arnab K Chatterjee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibodyEnrico Malito, Marco Biancucci, Agnese Faleri, et al.
Journal of Medicinal Chemistry|April 6, 2021
Structure-Based Design of Selective LONP1 Inhibitors for Probing <i>In Vitro</i> BiologyLaura J Kingsley, Xiaohui He, Matthew McNeill, et al.
Journal of Medicinal Chemistry|July 20, 2016
Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung CancersGérald Lelais, Robert Epple, Thomas H Marsilje, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory DiseasesXiaohui He, Sara Da Ros, John Nelson, et al.
Proteins|January 30, 2007
Crystal structure of a transcription regulator (TM1602) from Thermotoga maritima at 2.3 A resolutionDana Weekes, Mitchell D Miller, S Sri Krishna, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipelineScott A Lesley, Peter Kuhn, Adam Godzik, et al.
Proteins|July 26, 2006
Crystal structure of a glycerate kinase (TM1585) from Thermotoga maritima at 2.70 A resolution reveals a new foldRobert Schwarzenbacher, Daniel McMullan, S Sri Krishna, et al.
Proteins|November 16, 2007
Crystal structure of 2-keto-3-deoxygluconate kinase (TM0067) from Thermotoga maritima at 2.05 A resolutionIrimpan I Mathews, Daniel McMullan, Mitchell D Miller, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
The Biochemical Journal|July 31, 2013
Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureusChristina Schluepen, Enrico Malito, Ambra Marongiu, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2006
Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethersDavid C Tully, Hong Liu, Arnab K Chatterjee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibodyEnrico Malito, Marco Biancucci, Agnese Faleri, et al.
Journal of Medicinal Chemistry|April 6, 2021
Structure-Based Design of Selective LONP1 Inhibitors for Probing <i>In Vitro</i> BiologyLaura J Kingsley, Xiaohui He, Matthew McNeill, et al.
Journal of Medicinal Chemistry|July 20, 2016
Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung CancersGérald Lelais, Robert Epple, Thomas H Marsilje, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory DiseasesXiaohui He, Sara Da Ros, John Nelson, et al.
Proteins|January 30, 2007
Crystal structure of a transcription regulator (TM1602) from Thermotoga maritima at 2.3 A resolutionDana Weekes, Mitchell D Miller, S Sri Krishna, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2002
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipelineScott A Lesley, Peter Kuhn, Adam Godzik, et al.
Proteins|July 26, 2006
Crystal structure of a glycerate kinase (TM1585) from Thermotoga maritima at 2.70 A resolution reveals a new foldRobert Schwarzenbacher, Daniel McMullan, S Sri Krishna, et al.
Proteins|November 16, 2007
Crystal structure of 2-keto-3-deoxygluconate kinase (TM0067) from Thermotoga maritima at 2.05 A resolutionIrimpan I Mathews, Daniel McMullan, Mitchell D Miller, et al.
Pageof 11